MAM
Best Foods awards media duties to ZenithOptimedia
MUMBAI: ZenithOptimedia India has bagged the media planning and buying duties for Best Foods after a multi-agency pitch.
The business was won through a competitive pitch amongst the top four media buying agencies in New Delhi.
Best Foods is one of the largest rice producers, engaged in supply and trade of series of rice, health and wellness products.
“As traditional Indian companies expand their market base to an evolved consumer, in an over cluttered marketplace, it becomes imperative to communicate through effective communication mediums. Our neutral touch point approach will help optimise the best marketing mix for the launch. We are very excited to work on yet another launch in India and are confident of achieving the desired ROI,” said ZenithOptimedia India CEO Satyajit Sen.
Best Foods business director Aayushman Gupta added, “We are delighted to have ZenithOptimedia as our media partners for our India launch. It is their deep understanding on launching brands in India and their holistic approach to reaching all consumer touch points helped us decided on ZO. They are able to give Best a complete 360 solution to our go to market strategy.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
